SPARC independent drug delivery and antitumour effects ofnab-paclitaxel in genetically engineered mice
出版年份 2013 全文链接
标题
SPARC independent drug delivery and antitumour effects ofnab-paclitaxel in genetically engineered mice
作者
关键词
-
出版物
GUT
Volume 63, Issue 6, Pages 974-983
出版商
BMJ
发表日期
2013-09-26
DOI
10.1136/gutjnl-2013-305559
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- SPARC Expression Correlates with Tumor Response to Albumin-Bound Paclitaxel in Head and Neck Cancer Patients
- (2014) Neil Desai et al. Translational Oncology
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Phase II Trial of nab-Paclitaxel as Second-line Therapy in Patients With Advanced Pancreatic Cancer
- (2012) Peter J. Hosein et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
- (2012) Paolo P. Provenzano et al. CANCER CELL
- Tumor-Derived Granulocyte-Macrophage Colony-Stimulating Factor Regulates Myeloid Inflammation and T Cell Immunity in Pancreatic Cancer
- (2012) Lauren J. Bayne et al. CANCER CELL
- EMT and Dissemination Precede Pancreatic Tumor Formation
- (2012) Andrew D. Rhim et al. CELL
- Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
- (2012) Michael A Jacobetz et al. GUT
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
- (2012) Ravid Straussman et al. NATURE
- nab -Paclitaxel Potentiates Gemcitabine Activity by Reducing Cytidine Deaminase Levels in a Mouse Model of Pancreatic Cancer
- (2012) Kristopher K. Frese et al. Cancer Discovery
- The regulatory function of SPARC in vascular biology
- (2011) Lee B. Rivera et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- SPARC promotes pericyte recruitment via inhibition of endoglin-dependent TGF-β1 activity
- (2011) Lee B. Rivera et al. JOURNAL OF CELL BIOLOGY
- Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
- (2011) Daniel D. Von Hoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Response to nab-Paclitaxel Compared with Cremophor-Solubilized Paclitaxel is Independent of Secreted Protein Acidic and Rich in Cysteine Expression in Non-Small Cell Lung Cancer
- (2011) Huanjie Shao et al. Journal of Thoracic Oncology
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
- (2011) G. L. Beatty et al. SCIENCE
- Stromal SPARC expression and patient survival after chemoradiation for non-resectable pancreatic adenocarcinoma
- (2010) Tine S. Mantoni et al. CANCER BIOLOGY & THERAPY
- Stromal biology and therapy in pancreatic cancer
- (2010) A. Neesse et al. GUT
- Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma
- (2009) S. A. Arnold et al. Disease Models & Mechanisms
- C-Raf Inhibits MAPK Activation and Transformation by B-RafV600E
- (2009) Florian A. Karreth et al. MOLECULAR CELL
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status
- (2008) Neil P. Desai et al. ANTI-CANCER DRUGS
- Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction
- (2008) Mark W.M. Schellings et al. JOURNAL OF EXPERIMENTAL MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started